ROS1 and cancer: ROS1 fusion proteins are established oncogenic drivers in a diverse set of cancers, particularly in lung adenocarcinomas (Arai et al, 2013; Saborowski et al, 2013; Inoue et al, 2016; Lin & Shaw, 2017).